OR WAIT null SECS
July 02, 2011
A new report places pharmaceutical and healthcare companies ahead in corporate and social governance.
High demand could lead to innovation in controlled-release injectables.
Pharmaceutical manufacturers look to various solutions to resolve the challenge of poorly soluble drugs
The authors investigate the influence of hydro-alcoholic media on hydration and drug release from polyethylene oxide extended-release matrices.
The current review describes the role and selection of excipients, pellet core, coating materials, and compression with various cushioning agents.
June 02, 2011
Can microdosing make medicines safer and more effective for children?
The study results suggested that Pluronic F127 might be a potent inhibitor of drug precipitation for Labrasol formulations.
Effective containment in API and drug-product manufacturing encompasses a variety of process, equipment, and operational issues.
June 01, 2011
BASF's Jan Bebber explains why immediate-release formulations boost drug efficacy and aid patient compliance.
May 19, 2011
Teva Pharmaceutical Industries agreed to pay shareholders $460 million in cash to acquire a 57% stake in Taiyo Pharmaceutical Industry. Teva also will offer to buy all outstanding shares of Taiyo.